Cargando…
How many samples are needed to infer truly clonal mutations from heterogenous tumours?
BACKGROUND: Modern cancer treatment strategies aim to target tumour specific genetic (or epigenetic) alterations. Treatment response improves if these alterations are clonal, i.e. present in all cancer cells within tumours. However, the identification of truly clonal alterations is impaired by the t...
Autores principales: | Opasic, Luka, Zhou, Da, Werner, Benjamin, Dingli, David, Traulsen, Arne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6489174/ https://www.ncbi.nlm.nih.gov/pubmed/31035962 http://dx.doi.org/10.1186/s12885-019-5597-1 |
Ejemplares similares
-
Detecting truly clonal alterations from multi-region profiling of tumours
por: Werner, Benjamin, et al.
Publicado: (2017) -
Multiscale heterogeneity in gastric adenocarcinoma evolution is an obstacle to precision medicine
por: Röcken, Christoph, et al.
Publicado: (2021) -
Quantifying the HDL proteome by mass spectrometry: how many proteins truly associate with HDL?
por: Marsche, Gunther
Publicado: (2018) -
A deterministic model for the occurrence and dynamics of multiple mutations in hierarchically organized tissues
por: Werner, Benjamin, et al.
Publicado: (2013) -
The impact of phenotypic heterogeneity of tumour cells on treatment and relapse dynamics
por: Raatz, Michael, et al.
Publicado: (2021)